Home
Live Updates
Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF : comparemela.com
Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF
Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD.
Related Keywords
California ,
United States ,
San Diego ,
American ,
Paul Frohna ,
American Thoracic Society ,
International Conference ,
Endeavor Biomedicines ,
Novel Hedgehog Inhibitor ,
Increases Lung Function ,
Reduces Lung Fibrosis ,
Results From ,
Idiopathic Pulmonary Fibrosis ,
Placebo Controlled Phase ,
comparemela.com © 2020. All Rights Reserved.